The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme

Karla V. Ballman, Jan C. Buckner, Paul D. Brown, Caterina Giannini, Patrick J. Flynn, Betsy R. LaPlant, Kurt A. Jaeckle

Research output: Contribution to journal › Article › peer-review

237 Scopus citations

Fingerprint

Dive into the research topics of 'The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme'. Together they form a unique fingerprint.

Medicine & Life Sciences